348340 — Neuromeka Co Balance Sheet
0.000.00%
- KR₩388bn
- KR₩429bn
- KR₩25bn
Annual balance sheet for Neuromeka Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,605 | 15,837 | 28,520 | 40,941 | 20,025 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 750 | 2,709 | 6,885 | 7,673 | 9,766 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8,602 | 22,075 | 39,353 | 55,824 | 42,380 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,092 | 1,758 | 4,007 | 14,027 | 25,871 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 12,057 | 24,334 | 43,830 | 95,721 | 95,230 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9,070 | 8,479 | 4,022 | 50,801 | 58,241 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 9,871 | 8,769 | 4,103 | 71,665 | 84,360 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 2,186 | 15,565 | 39,727 | 24,056 | 10,869 |
| Total Liabilities & Shareholders' Equity | 12,057 | 24,334 | 43,830 | 95,721 | 95,230 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |